21-OHD

Clinical trials for 21-OHD explained in plain language.

Never miss a new study

Get alerted when new 21-OHD trials appear

Sign up with your email to follow new studies for 21-OHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for kids with rare hormone disorder: drug may cut steroid doses

Disease control Terminated

This study tested a drug called tildacerfont in children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if the drug is safe and can help control the disease while allowing children to ta…

Matched conditions: 21-OHD

Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated Apr 26, 2026 19:36 UTC

21-OHD

Get alerted when new 21-OHD trials appear

New hope for kids with rare hormone disorder: drug may cut steroid doses